Matthew Greenberg

Matthew Greenberg is a Senior Analyst at Scopia Capital Management LP, a prominent investment management firm based in New York City. In this role, he leads in-depth research and investment analysis, contributing to the firm's fundamental long-short equity strategies. His current responsibilities include evaluating public equities and supporting portfolio decisions across Scopia’s institutional client base.

Greenberg has a demonstrated track record covering the healthcare sector, particularly pharmaceuticals and medical technology, as well as additional experience in consumer and industrials research. Prior to Scopia, he served as Senior Analyst at Center Lake Capital and was Principal at Valinor Management, L.P., focusing on similar fundamental equity strategies with an emphasis on high-conviction, value-oriented investments.

He holds a Bachelor of Science in Finance & Accounting from the Wharton School at the University of Pennsylvania, equipping him with rigorous financial modeling, valuation, and accounting expertise. Greenberg is recognized for his analytical skills and sector knowledge, making significant contributions to security selection and portfolio construction at leading alternative asset management firms in his career.